Alnylam Pharmaceuticals Inc <ALNY.O>: BofA Global Research cuts price objective to $346 from $410
ALNY•Related News
EuroDry updates financial calendar with second-quarter results release, conference call and webcast
EDRY•
VistaGen names Douglas J. Williamson to board of directors
VTGN•
Chemed Corporation <CHE.N>: Oppenheimer raises target price to $590 from $500
CHE•
Granite Construction <GVA.N>: Oppenheimer raises target price to $180 from $170
GVA•
GLOBAL MARKETS-Stocks climb as strong tech results reignite AI trade, yen swings
SPY•